Abstract:
Coptis teeta, is a non-timber forest product (NTFP) that grows in northwest Yunnan (China), Bhutan and northeast India, specially in temperate regions of Arunachal Pradesh. Rhizome of this plant is very famous in traditional medication in North East India and China, for prevention and treatment of a number of human diseases. Destructive commercial harvesting for centuries and deforestation, this species has entered into the Chinese Red Data Book, due to its high market demand, commercial harvesting pressure on wild populations that were already dwindling as a result of deforestation and population reach at risk of extinction. On the basis of the various reports and studies
Coptis teeta contains many alkaloids such as berberine, palmatine, jatrorrhizine, coptisine, columbamine, and epiberberine and various secondary metabolites, lignans, phenylpropanoids, flavonoids, phenolic acids, saccharides and steroids are also present in
Coptis teeta. Thus, the qualitative and quantitative analysis of several high-content constituents in
Coptis extracts will help us for better evaluation and regulation of drug quality. Due to its versatile nature and many pharmacological benefits the cultivation and propagation of
Coptis teeta should be done with proper care and patience.